"Sarissa Capital Management LP bought a new stake in Advaxis Inc. (NASDAQ:ADXS) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 600,000 shares of the biotechnology company’s stock, valued at approximately $4,853,000. Advaxis comprises 1.4% of Sarissa Capital Management LP’s holdings, making the stock its 11th largest position. Sarissa Capital Management LP owned approximately 1.75% of Advaxis at the end of the most recent quarter.
Swiss National Bank raised its position in Advaxis by 11.0% in the second quarter. Swiss National Bank now owns 53,500 shares of the biotechnology company’s stock valued at $433,000 after buying an additional 5,300 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in Advaxis by 115.0% in the second quarter. PNC Financial Services Group Inc. now owns 21,500 shares of the biotechnology company’s stock valued at $173,000 after buying an additional 11,500 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Advaxis by 10.4% in the second quarter. Bank of New York Mellon Corp now owns 164,368 shares of the biotechnology company’s stock valued at $1,330,000 after buying an additional 15,543 shares in the last quarter. Squarepoint Ops LLC increased its stake in Advaxis by 210.8% in the first quarter. Squarepoint Ops LLC now owns 63,100 shares of the biotechnology company’s stock valued at $570,000 after buying an additional 42,800 shares in the last quarter. Finally, California State Teachers Retirement System increased its stake in Advaxis by 9.0% in the second quarter. California State Teachers Retirement System now owns 70,041 shares of the biotechnology company’s stock valued at $567,000 after buying an additional 5,789 shares in the last quarter. Hedge funds and other institutional investors own 55.58% of the company’s stock."
Stock is extremely undervalued!